Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.016 | 0.8 |
mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.0096 | 0.8 |
mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.014 | 0.8 |
mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |